trial

mHealth for Psychosis Help-seeking

NCTId NCT05905601
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 60 (actual)
Sponsored by University of Washington
Primary completion 2024-07-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
60 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2023-06-15
Primary completion
2024-07-03
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
NORTH "Full"NORTH "Lite"

Sponsors

University of WashingtonLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Benjamin Buck, PhDPrincipal Investigator

Sites

1 total
Seattle, United States

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2024-07-03
Status
COMPLETED
relationships
The graph out of here
drug
NORTH "Full"
drug
NORTH "Lite"
drug
lead_sponsor
University of Washington
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Benjamin Buck, PhD
person